Food choices influence the risk of some cancers, but there is no single cancer-proof diet. The strongest evidence concerns whole grains and fiber, processed meat, alcohol and long-term dietary patterns.

Can Ivermectin or Fenbendazole Cure Cancer?
CancerSnoop Claim Check
Can Ivermectin or Fenbendazole Cure Cancer?
Verdict · DANGEROUS
Personal stories often promote ivermectin or fenbendazole for cancer. Neither drug has been shown to cure cancer in people. The two drugs have different approved uses, human evidence and safety concerns.
Claim Statement
People with cancer can use ivermectin or fenbendazole as a cure and replace or delay oncology treatment.
Claim Origin
Online accounts often put both drugs under one label because they treat parasites. Some accounts also describe people receiving other cancer treatments at the same time.
Ivermectin or fenbendazole for cancer: what evidence is available?
The FDA describes approved human uses for specific ivermectin products, including certain parasitic infections. Approval is for particular formulations and indications. It cannot be carried over to a different disease. A registered phase II trial is evaluating ivermectin in combination with an immunotherapy drug in people with metastatic triple-negative breast cancer. Its questions include safety and whether tumors respond to the combination. The registry describes a study, not a demonstration of a cure or evidence that ivermectin works on its own. [1] [2]
What human reports say about fenbendazole
A published case described a patient with non-small cell lung cancer who took fenbendazole after reading about it on social media. The patient developed liver injury. The report describes improvement after the drug was stopped and did not document tumor shrinkage attributable to fenbendazole. One case cannot tell you how common a complication is. It can flag a harm that investigators and clinicians should take seriously. The NIH LiverTox review also describes clinically apparent liver injury associated with fenbendazole. [3] [4]
Why testimonials and lab results answer different questions
A laboratory experiment can show whether cells respond under a particular set of conditions. A human case can show what happened to one person. To establish that a drug helped, researchers need to address alternative explanations, including concurrent treatments, the timing of earlier therapy and how the tumor was measured. Before-and-after images on social media may leave out those details. Even a confirmed improvement after starting a combination cannot identify which part of that combination caused it without an appropriate comparison.
A clinical study also needs a meaningful endpoint. Tumor shrinkage, symptom improvement and longer survival are different outcomes. Evidence for one of those outcomes would still need to be interpreted for the type and stage of cancer studied.
What information helps an oncology team assess exposure?
If you or someone you care for has already taken either drug, tell the oncology team which product was used and bring the label or a photo. Note when it was taken and report new symptoms or abnormal test results. This helps the team evaluate what might be contributing and avoid making treatment decisions with incomplete information. If you want to know whether a trial applies to your case, ask about the cancer subtype, the study’s eligibility rules and the evidence that would be needed before any change in care.
How to read a claim that a drug is being studied
Find the registry entry and check whether the study is testing the drug by itself or together with another treatment. Check what the study plans to measure and whether it has reported results. A listed trial can describe a plausible research question without resolving it. A credible report should also explain who was studied and what adverse events occurred.
When you read about ivermectin or fenbendazole for cancer, look for which drug was tested, what it was compared with and what patients experienced.
Sources and References
- Ivermectin and COVID-19
- Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
- Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information
- Fenbendazole
